ACCC is committed to help ensure access to recommended care for patients who receive treatment for multiple myeloma or acute lymphoblastic leukemia (ALL) through a partnership with the American Cancer Society and Project ECHO. The educational focus will be on bringing the latest content knowledge and best practices in the treatment of these hematological cancer patients to your cancer care team.
Participation in the TeleECHO Clinic is free. The clinics will convene by videoconference each month.
Each session of the Advances in Multiple Myeloma and Acute Lymphoblastic Leukemia TeleECHO Clinic includes a short talk on a topic related to the treatment of these hematological cancer patients and review of patient cases submitted by spoke site participants. Topics include:
This program will provide specialty multiple myeloma and acute lymphoblastic leukemia cancer treatment information and training to healthcare providers to help build their capacity to provide high-quality, best-practice care locally for patients and thereby increase access to care across the nation.
Contact Monique Dawkins, EdD, MPA, for information on how to participate.
In 2020, the American Cancer Society and Project ECHO partnership will also bring TeleECHO sessions focused on Colorectal Cancer and Bone Health in Patients with Breast and Prostate cancer. Information on the Colorectal ECHO TeleClinics is available here. Information on the Bone Health ECHO clinics will be available soon.
Guided by an expert Advisory Committee, this ACCC education project aims to support the multidisciplinary cancer care team in diagnosing, testing, and treating patients with multiple myeloma. This project seeks to:
The ACCC Multidisciplinary Multiple Myeloma (MM) Visiting Experts Workshop Series offers an exceptional opportunity for ACCC Cancer Program Members to host a full-day multiple myeloma-focused workshop on-site at your facility. This expert-led education session is designed to benefit the entire multidisciplinary oncology care team.
The ACCC educational initiative, The Transplant Treatment Path: Optimizing Patient-Centered Care for ASCT in Multiple Myeloma aimed at improving provider communication to optimize the treatment of multiple myeloma patients in the community cancer center pre- and post-autologous stem cell transplant (ASCT).